Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2012
12/13/2012US20120316380 Pyrazolo Piperidine Derivatives as NADPH Oxidase Inhibitors
12/13/2012US20120316245 Co-crystals of agomelatine, a process for there preparation and pharmaceutical compositions containing them
12/13/2012US20120316234 Anthraquinone -based compound, the synthesis processes and the application thereof
12/13/2012US20120316230 Compounds and their Salts Specific to the PPAR Receptors and the EGF Receptors and their Use in the Medical Field
12/13/2012US20120316225 Modified INSM1-Promoter for Neuroendocrine Tumor Therapy and Diagnostics
12/13/2012US20120316224 Novel nucleic acid prodrugs and methods of use thereof
12/13/2012US20120316223 MODULATION OF pre-mRNA USING SPLICE MODULATING OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS IN THE TREATMENT OF DISEASE
12/13/2012US20120316204 Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
12/13/2012US20120316203 Compositions and Methods for Inhibition of Cancers
12/13/2012US20120316198 Hydrazone and diacyl hydrazine compounds and methods of use
12/13/2012US20120316193 Proteostasis regulators
12/13/2012US20120316192 Substituted indolo [2,3-a] quinolizines
12/13/2012US20120316186 Deazapurines useful as inhibitors of janus kinases
12/13/2012US20120316174 Disubstituted phthalazine hedgehog pathway antagonists
12/13/2012US20120316171 Tryptophan Hydroxylase Inhibitors for the Treatment of Cancer
12/13/2012US20120316169 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them
12/13/2012US20120316166 Hetarylaminonaphthyridines
12/13/2012US20120316164 Method for inhibiting the growth of cancer stem cells
12/13/2012US20120316163 Pyrazolo Piperidine Derivatives as NADPH Oxidase Inhibitors
12/13/2012US20120316162 Piperidine and piperazine derivatives
12/13/2012US20120316159 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
12/13/2012US20120316155 Imidazole-2,4-Dione Inhibitors of Casein Kinase 1
12/13/2012US20120316152 Substituted isoquinolineand isoquinolinone derivatives
12/13/2012US20120316151 Triazolones as fatty acid synthase inhibitors
12/13/2012US20120316150 Amide compounds useful in therapy
12/13/2012US20120316149 Heterocyclic sulfonamide derivatives
12/13/2012US20120316148 Compositions and Methods for Modulating a Kinase
12/13/2012US20120316147 Novel pyridine derivatives
12/13/2012US20120316145 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzylidene derivatives, methods for the production thereof and use thereof for treating diseases
12/13/2012US20120316139 Anti-inflammatory compounds and uses thereof
12/13/2012US20120316137 Methods and Compositions for Treating Cancer
12/13/2012US20120316135 Compounds for Inhibiting Cell Proliferation in EGFR-Driven Cancers
12/13/2012US20120316127 Method of manufacturing coating agent for drug releasing stent and coating agent for drug releasing stent manufactured thereby
12/13/2012US20120316119 Peptide composition for cancer treatment by inhibiting trpv6 calcium channel activity
12/13/2012US20120316117 Process to produce fibrillar proteins and method of treatment using fibrillar proteins
12/13/2012US20120316115 Methods and compositions for inhibiting angiogenesis
12/13/2012US20120316111 BMP-2 Upregulating Compounds For Healing Bone Tissue And Screening Methods For Selecting Such Compounds
12/13/2012US20120316101 Peptides for targeting apoptotic cells and uses thereof
12/13/2012US20120316066 Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex
12/13/2012US20120315634 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
12/13/2012US20120315324 Exosomal compositions and methods for the treatment of disease
12/13/2012US20120315320 Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensivity and radiosensitivity in tumor or cancer cells
12/13/2012US20120315309 Modified pectins, compositions and methods related thereto
12/13/2012US20120315306 Pharmaceutical composition and preparation for oral administration
12/13/2012US20120315304 Sensitization of immune system against haptenized melanoma antigens
12/13/2012US20120315298 Local treatment of neurofibromas
12/13/2012US20120315293 Antigen Delivery Vectors and Constructs
12/13/2012US20120315291 Purine derivatives and their pharmaceutical uses
12/13/2012US20120315290 Inhibitors of ll-37 mediated immune reactivity to self nucleic acids
12/13/2012US20120315287 Mic-binding antibodies and methods of use thereof
12/13/2012US20120315286 Compositions and methods related to tim 3, a th1-specific cell surface molecule
12/13/2012US20120315284 Composition for enhancing trail sensitivity comprising inhibitors for expression or activity of tip41 as a target gene of trail sensitizer
12/13/2012US20120315282 Antibodies Specific for TGF-Beta
12/13/2012US20120315279 Compositions and method of modulating growth factor function
12/13/2012US20120315273 Treating skin cancer
12/13/2012US20120315268 Combination therapy of an afucosylated cd20 antibody with bendamustine
12/13/2012US20120315267 Novel uses
12/13/2012US20120315265 Hydrogel-forming polymer, and preparation process and uses thereof
12/13/2012US20120315254 Methods and compositions for enhancing fat graft survival
12/13/2012US20120315252 Methods of Reducing Teratoma Formation During Allogeneic Stem Cell Therapy
12/13/2012US20120315248 Compositions and methods for treating cancer with attenuated oncolytic viruses
12/13/2012US20120315247 Compounds comprising a spiro-ring and methods of use
12/13/2012US20120315245 Immunomodulator polypeptides derived from il-2 and their use thereof in the therapeutic of cancer and chronic infections
12/13/2012US20120315244 Methods for Modulation of Autophagy Through the Modulation of Autophagy-Inhibiting Gene Products
12/13/2012US20120315220 Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use
12/13/2012US20120315219 Drug Delivery Coating For Use With A Stent
12/13/2012US20120315217 Inverse agonists and neutral antagonists for the tsh receptor
12/13/2012US20120315216 Compositions and Methods for Treating and Diagnosing Cancer
12/13/2012CA2838885A1 Pyrimido[4,5-d]pyrimidinyl compounds, pharmaceutical compositions and use thereof
12/13/2012CA2838604A1 Metal chelating compositions and methods for controlling the growth or activities of a living cell or organism
12/13/2012CA2838458A1 Modulators of adp-dependent glucokinase (adpgk) and glycerol-3-phosphate dehydrogenase (gpd2) for therapy
12/13/2012CA2838401A1 New taccalonolide microtubule stabilizers
12/13/2012CA2838387A1 Use of metallocene compounds for cancer treatment
12/13/2012CA2838186A1 Scaffold-kinase interaction blockades and uses thereof in treating cancer
12/13/2012CA2838029A1 Heterocyclic sulfonamide derivatives
12/13/2012CA2837703A1 Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant
12/13/2012CA2837563A1 Methods and compositions for treating brain cancer
12/13/2012CA2836227A1 Substituted pyridopyrazines as novel syk inhibitors
12/13/2012CA2834610A1 Rna interference mediated inhibition of isocitrate dehydrogenase (idh1) gene expression
12/13/2012CA2833771A1 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
12/12/2012EP2532747A1 Modulators of ADP-dependent glucokinase (ADPGK) and glycerol-3-phosphate dehydrogenase (GPD2) for therapy
12/12/2012EP2532743A1 Pharmaceutical composition for treatment and/or prevention of cancer
12/12/2012EP2532681A1 Anti-ILT7 antibody
12/12/2012EP2532680A1 Medicinal composition for treating and/or preventing cancer
12/12/2012EP2532673A2 Tubulysine derivatives
12/12/2012EP2532671A1 Novel synthetic glycolipid and use thereof
12/12/2012EP2532667A1 Deazapurines useful as inhibitors of janus kinases
12/12/2012EP2532666A1 Pharmaceutically acceptable salts of pyrrolo-nitrogenous heterocyclic derivatives, preparation method and medical use thereof
12/12/2012EP2532664A1 Substituted indolo [2,3-a] quinolizines in the treatment of cancer
12/12/2012EP2532659A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
12/12/2012EP2532657A2 Compounds and methods of use
12/12/2012EP2532650A2 Modulators of ATP-binding cassette transporters
12/12/2012EP2532649A1 Amino lipids, their synthesis and uses thereof
12/12/2012EP2532367A1 Pharmaceutical agent for treatment and/or prevention of cancer
12/12/2012EP2532366A1 Pharmaceutical composition for treating and/or preventing cancer
12/12/2012EP2532365A1 Pharmaceutical composition for treatment and/or prevention of cancer
12/12/2012EP2532364A1 Pharmaceutical composition for treating and/or preventing cancer
12/12/2012EP2532235A1 Inhibitors of bruton's tyrosine kinase
12/12/2012EP2532234A1 Inhibitors of bruton's tyrosine kinase
12/12/2012EP2531616A1 Diagnostic and prognostic assay for breast cancer
1 ... 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 ... 2211